Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Raphael Pharmaceutical Inc. Stock Analysis RAPH
United States N/A Nano Cap Raphael Pharmaceutical, Inc. is a clinical-stage biotechnology company. The firm is focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol (CBD) oil. The firm has completed the study for its lead product candidate for the treatment of rheumatoid arthritis (RA), and is developing asthma product candidates, which are in the pre-clinical-stage. The firm is also continuing to investigate its product for the treatment of autoimmune diseases. The Company’s discovery platform focuses on the use of CBD oil, one of the cannabinoids in cannabis plants, as the active pharmaceutical ingredient (API), for its RA product candidate and COVID-19 product candidate.
Read More Raphael Pharmaceutical Inc (RAPH) Chart
Key Statistics of Raphael Pharmaceutical Inc (RAPH)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.40Volume
100.00P/E Ratio (TTM)
-52 Week Range
Market Cap
28.25MAvg. Volume
180.00Dividend Yield
-Financial Metrics & Statements of Raphael Pharmaceutical Inc (RAPH)
FAQ's for Raphael Pharmaceutical Inc (RAPH)
- According to Musaffa’s Shariah screening methodology, Raphael Pharmaceutical Inc (RAPH) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Raphael Pharmaceutical Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Raphael Pharmaceutical Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Raphael Pharmaceutical Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Raphael Pharmaceutical Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Raphael Pharmaceutical Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.